Suppr超能文献

联合远程电子监测与抗精神病药物血药浓度用于评估精神分裂症患者治疗依从性:一项前瞻性研究的结果

The use of combined remote electronic monitoring and blood concentrations of antipsychotics for assessment of therapeutic adherence in patients with schizophrenia: results of a prospective study.

作者信息

Šilhán Petr, Hýža Martin, Ambroš Samuel, Dostálek Petr, Schwarzová Jana, Skřont Tomáš, Perničková Denisa, Baarová Pavla, Augustynek Martin, Kacířová Ivana, Uřinovská Romana

机构信息

Department of Psychiatry, University Hospital Ostrava, 17. listopadu 1790, Ostrava, Poruba, 708 52, Czech Republic.

Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.

出版信息

BMC Psychiatry. 2025 May 22;25(1):523. doi: 10.1186/s12888-025-06981-3.

Abstract

BACKGROUND

Schizophrenia is a serious mental illness, the pharmacological treatment of which comprises primarily the use of antipsychotics. However, non-adherence to their use and its reliable determination present a serious clinical and economic problem. This study aimed to determine therapeutic adherence in outpatients with schizophrenia spectrum disorders by combining short-term electronic monitoring of dispenser opening with the measurement of antipsychotic blood concentrations.

METHODS

A total of 55 patients underwent a week-long electronic monitoring of dispenser opening and measurement of blood concentrations before and after monitoring. Patients who correctly opened the dispenser at least in 80% of scheduled time points during the weekly interval and, at the same time, did not show a change in blood concentration of the antipsychotic by more than 30% in any direction, were considered adherent.

RESULTS

69.1% of the patients met the adherence criteria, which was less than that determined by the Drug Attitude Inventory (DAI-10), the Visual Analogue Scale (VAS), and the Clinician Rating Scale (CRS). 7.3% of the patients took less than 80% of the prescribed doses and a change in blood concentrations of the antipsychotic by more than 30% was detected in 25.4% of the patients. In 70.9% of patients, the detected concentrations were within the recommended therapeutic reference interval. The groups of adherent and non-adherent patients did not differ statistically significantly in the severity of their illness as determined by the Clinical Global Impression (CGI), the Personal and Social Performance scale (PSP), and the Positive and Negative Syndrome Scale (PANSS).

CONCLUSIONS

The combined method of evaluating adherence in schizophrenia patients confirmed the results determined by other methods. The benefits of this approach are described in the paper.

摘要

背景

精神分裂症是一种严重的精神疾病,其药物治疗主要包括使用抗精神病药物。然而,不坚持用药及其可靠判定是一个严重的临床和经济问题。本研究旨在通过结合短期电子监测药瓶开启情况与抗精神病药物血药浓度测量来确定精神分裂症谱系障碍门诊患者的治疗依从性。

方法

共有55例患者接受了为期一周的药瓶开启电子监测以及监测前后的血药浓度测量。在每周的时间间隔内,至少在80%的预定时间点正确开启药瓶,且同时抗精神病药物血药浓度在任何方向上变化不超过30%的患者被视为依从性良好。

结果

69.1%的患者符合依从性标准,这一比例低于通过药物态度量表(DAI - 10)、视觉模拟量表(VAS)和临床医生评定量表(CRS)所确定的比例。7.3%的患者服用的药物剂量不足规定剂量的80%,25.4%的患者抗精神病药物血药浓度变化超过30%。在70.9%的患者中,检测到的血药浓度在推荐的治疗参考区间内。根据临床总体印象量表(CGI)、个人和社会功能量表(PSP)以及阳性和阴性症状量表(PANSS)确定,依从性良好和不依从的患者组在疾病严重程度上无统计学显著差异。

结论

评估精神分裂症患者依从性的联合方法证实了其他方法所确定的结果。本文描述了这种方法的优点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05f8/12101024/64e4cfed4593/12888_2025_6981_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验